Clinical Research Directory
Browse clinical research sites, groups, and studies.
Transcriptional Analysis of Mechanisms in Liver Failure and Sepsis
Sponsor: University of Cambridge
Summary
Context Acute liver failure (ALF) is a life-threatening condition that occurs on the background of a healthy liver. The most common cause of acute liver failure in the UK is paracetamol overdose. Acute liver failure results from liver damage and activation of the body's inflammatory defences with subsequent damage to other organs including kidneys, lungs and heart. This often requires life support in an intensive care unit before liver transplantation (LT), the only currently available and effective rescue treatment for acute liver failure. Challenge Patient factors and organ availability limit who can benefit from liver transplant. At present there are no effective alternative therapies for patients who do not get a liver transplant, and survival rates in these situations are poor. The underlying mechanisms of inflammation are poorly understood, thus therapies are limited. Aim The investigators research aims to understand the mechanisms that underpin the inflammation seen in acute liver failure by studying the inflammatory cells in the blood and examining their cellular programmes. This will allow the investigators to identify pathways that are activated and understand how the liver and blood interact to spread inflammation around the body. The investigators aim to identify targets for disease-modifying therapies to avert the need for liver transplant. Importance Understanding how the body responds to acute liver failure, and whether there are different patterns of inflammatory response, will enable trials of immune-modulating drugs to prevent the need for liver transplantation or prolong the time a patient can wait for an organ. This has the potential to help improve organ availability for other patients and save lives in acute liver failure.
Official title: Transcriptional Analysis of Mechanisms and Predictors in Acute Liver Failure and Sepsis
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
100
Start Date
2025-09
Completion Date
2028-09
Last Updated
2025-08-26
Healthy Volunteers
No
Conditions
Interventions
blood draw
Venous blood sampling into Tempus tube for RNA-sequencing
Locations (7)
University Hospitals Birmingham
Birmingham, United Kingdom
Addenbrooke's Hospital
Cambridge, United Kingdom
Royal Infirmary of Edinburgh
Edinburgh, United Kingdom
Leeds General Infirmary
Leeds, United Kingdom
Kings College Hospital
London, United Kingdom
Royal Free Hospital
London, United Kingdom
Freeman Hospital
Newcastle, United Kingdom